James N. Hollenhorst
Director/Board Member at Gen9, Inc.
Profile
James N.
Hollenhorst is currently a Director at Gen9, Inc. He was previously a Senior Director-Technology at Agilent Technologies, Inc. Hollenhorst holds a graduate degree and a doctorate from Stanford University and an undergraduate degree from the University of Minnesota.
James N. Hollenhorst active positions
| Companies | Position | Start |
|---|---|---|
Gen9, Inc.
 Gen9, Inc. BiotechnologyHealth Technology Gen9, Inc. engages in the development of synthetic biology technologies. It transforms synthetic biology by creating technologies to increase innovation within several industries including biopharmaceuticals, fine chemicals and bio-fuels. The company was founded by Joseph M. Jacobson, George Church and Drew Endy in 2009 and is headquartered in Cambridge, MA. | Director/Board Member | - |
Former positions of James N. Hollenhorst
| Companies | Position | End |
|---|---|---|
| AGILENT TECHNOLOGIES, INC. | Corporate Officer/Principal | - |
Training of James N. Hollenhorst
| University of Minnesota | Undergraduate Degree |
| Stanford University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| AGILENT TECHNOLOGIES, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Gen9, Inc.
Gen9, Inc. BiotechnologyHealth Technology Gen9, Inc. engages in the development of synthetic biology technologies. It transforms synthetic biology by creating technologies to increase innovation within several industries including biopharmaceuticals, fine chemicals and bio-fuels. The company was founded by Joseph M. Jacobson, George Church and Drew Endy in 2009 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- James N. Hollenhorst
